Changes in extracellular matrix in subcutaneous small resistance arteries of patients with essential hypertension

Abstract Background: In the development of hypertensive microvascular remodeling, a relevant role may be played by changes in extracellular matrix proteins. Aim of this study was the to evaluate some extracellular matrix components within the tunica media of subcutaneous small arteries in 9 normotensive subjects and 12 essential hypertensive patients, submitted to a biopsy of subcutaneous fat from the gluteal or the anterior abdominal region. Patients and Methods: Subcutaneous small resistance arteries were dissected and mounted on an isometric myograph, and the tunica media to internal lumen ratio was measured. In addition, fibronectin, laminin, transforming growth factor-beta-1 (TGF-β1) and emilin-1 contents within the tunica media were evaluated by immunofluorescence and relative immunomorphometrical analysis (immunopositivity % of area). The total collagen content and collagen subtypes within the tunica media were evaluated using both Sirius red staining (under polarized light) and immunofluorescence assay. Results: Normotensive controls had less total and type III collagen in respect with hypertensive patients. Fibronectin and TGF-β1 tunica media content was significantly greater in essential hypertensive patients, compared with normotensive controls, while laminin and emilin-1 tunica media content was lesser in essential hypertensive patients, compared with normotensive controls. A significant correlation was observed between fibronectin tunica media content and media to lumen ratio. Conclusions: Our results indicate that, in small resistance arteries of patients with essential hypertension, a relevant fibrosis may be detected; fibronectin and TGF-β1 tunica media content is increased, while laminin and emilin-1 content is decreased; these changes might be involved in the development of small resistance artery remodeling in humans.

[1]  Noriko Daneshtalab,et al.  Elastin microfibril interface-located protein 1, transforming growth factor beta, and implications on cardiovascular complications. , 2017, Journal of the American Society of Hypertension : JASH.

[2]  L. Rodella,et al.  Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats , 2017, International journal of molecular sciences.

[3]  L. Rodella,et al.  Acute mercury exposition of virgin, pregnant, and lactating rats: Histopathological kidney and liver evaluations , 2017, Environmental toxicology.

[4]  D. Rizzoni,et al.  Microvascular structure as a prognostically relevant endpoint. , 2017, Journal of hypertension.

[5]  S. Parapuram,et al.  TGF-β induces phosphorylation of phosphatase and tensin homolog: implications for fibrosis of the trabecular meshwork tissue in glaucoma , 2017, Scientific Reports.

[6]  J. McClure,et al.  Identification of a common molecular pathway in hypertensive renal damage: comparison of rat and human gene expression profiles , 2015, Journal of hypertension.

[7]  K. Matsuki,et al.  The role of transforming growth factor β1 in the regulation of blood pressure. , 2014, Current hypertension reviews.

[8]  E. Porteri,et al.  Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery , 2013, Blood pressure.

[9]  R. Reed,et al.  Arterial damage precedes the development of interstitial damage in the nonclipped kidney of two-kidney, one-clip hypertensive rats , 2013, Journal of hypertension.

[10]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[11]  G. Lembo,et al.  Vascular Smooth Muscle Emilin-1 Is a Regulator of Arteriolar Myogenic Response and Blood Pressure , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[12]  G. Boari,et al.  Thrombospondin-1 in Early Flow-Related Remodeling of Mesenteric Arteries from Young Normotensive and Spontaneously Hypertensive Rats , 2012, The open cardiovascular medicine journal.

[13]  M. Mulvany.  Small artery remodelling in hypertension. , 2012, Basic & clinical pharmacology & toxicology.

[14]  D. Sheppard,et al.  Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix. , 2011, Cold Spring Harbor perspectives in biology.

[15]  T. Nakayama,et al.  Association study of the elastin microfibril interfacer 1 (EMILIN1) gene in essential hypertension. , 2010, American journal of hypertension.

[16]  C. de Ciuceis,et al.  Altered structure of small cerebral arteries in patients with essential hypertension , 2009, Journal of hypertension.

[17]  Adrian Pistea,et al.  Transglutaminases in Vascular Biology: Relevance for Vascular Remodeling and Atherosclerosis , 2008, Journal of Vascular Research.

[18]  Marta Ruiz-Ortega,et al.  TGF-β signaling in vascular fibrosis , 2007 .

[19]  Marta Ruiz-Ortega,et al.  TGF-beta signaling in vascular fibrosis. , 2007, Cardiovascular research.

[20]  E. Heerkens,et al.  Integrins, vascular remodeling, and hypertension. , 2007, Hypertension.

[21]  S. Dupont,et al.  Emilin1 Links TGF-β Maturation to Blood Pressure Homeostasis , 2006, Cell.

[22]  J. Mullins,et al.  &agr;V Integrins Are Necessary for Eutrophic Inward Remodeling of Small Arteries in Hypertension , 2006, Hypertension.

[23]  C. de Ciuceis,et al.  Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. , 2006, The Journal of clinical endocrinology and metabolism.

[24]  S. Ledbetter,et al.  Neutralization of transforming growth factor-β attenuates hypertension and prevents renal injury in uremic rats , 2005, Journal of hypertension.

[25]  E. Porteri,et al.  Effects of olmesartan and enalapril at low or high doses on cardiac, renal and vascular interstitial matrix in spontaneously hypertensive rats , 2005, Blood pressure.

[26]  C. de Ciuceis,et al.  Effect of Treatment With Candesartan or Enalapril on Subcutaneous Small Artery Structure in Hypertensive Patients With Noninsulin-Dependent Diabetes Mellitus , 2005, Hypertension.

[27]  Jop Perree,et al.  Small Artery Remodeling Depends on Tissue-Type Transglutaminase , 2004, Circulation research.

[28]  E. Schiffrin,et al.  Vascular stiffening and arterial compliance. Implications for systolic blood pressure. , 2004, American journal of hypertension.

[29]  E. Schiffrin.  Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. , 2004, American journal of hypertension.

[30]  E. Schiffrin,et al.  From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. , 2004, American journal of physiology. Heart and circulatory physiology.

[31]  E. Schiffrin,et al.  Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system. , 2004, American journal of hypertension.

[32]  E. Schiffrin,et al.  Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats , 2004, Hypertension.

[33]  C. de Ciuceis,et al.  Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans , 2003, Journal of hypertension.

[34]  C. de Ciuceis,et al.  Prognostic Significance of Small-Artery Structure in Hypertension , 2003, Circulation.

[35]  E. Schiffrin,et al.  Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling , 2003, Hypertension.

[36]  E. Porteri,et al.  Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. , 2003, Journal of hypertension.

[37]  E. Schiffrin,et al.  Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism , 2003, Journal of hypertension.

[38]  E. Schiffrin,et al.  Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress , 2002, Hypertension.

[39]  C. Stier,et al.  Aldosterone as a Mediator in Cardiovascular Injury , 2002, Cardiology in review.

[40]  E. Schiffrin,et al.  Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. , 2002, American journal of hypertension.

[41]  Ernesto L. Schiffrin,et al.  Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis , 2001, Hypertension.

[42]  E. Porteri,et al.  Structural Alterations in Subcutaneous Small Arteries of Normotensive and Hypertensive Patients With Non–Insulin-Dependent Diabetes Mellitus , 2001, Circulation.

[43]  E. Schiffrin,et al.  Structure and Mechanical Properties of Resistance Arteries in Hypertension: Role of Adhesion Molecules and Extracellular Matrix Determinants , 2000, Hypertension.

[44]  K. Weber.  Fibrosis and hypertensive heart disease , 2000, Current opinion in cardiology.

[45]  E. Porteri,et al.  Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. , 2000, Hypertension.

[46]  E. Schiffrin,et al.  System Journal of Renin-angiotensin-aldosterone Journal of Renin-angiotensin-aldosterone System Essential Hypertension Reduction of Resistance Artery Stiffness by Treatment with the At1-receptor Antagonist Losartan in Journal of Renin-angiotensin-aldosterone System Additional Services and Informatio , 2022 .

[47]  J. Egido,et al.  Regulation of matrix proteins and impact on vascular structure , 2000, Current hypertension reports.

[48]  M. Suthanthiran,et al.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Cooper,et al.  Cellular mechanisms of diabetic vascular hypertrophy. , 1999, Microvascular research.

[50]  E. Schiffrin,et al.  Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. , 1999, Hypertension.

[51]  E. Porteri,et al.  Vascular hypertrophy and remodeling in secondary hypertension. , 1996, Hypertension.

[52]  M. Mulvany,et al.  Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension , 1996, Journal of hypertension.

[53]  S. Nag.  Immunohistochemical Localization of Extracellular Matrix Proteins in Cerebral Vessels in Chronic Hypertension , 1996, Journal of neuropathology and experimental neurology.

[54]  M. Mulvany,et al.  Small artery structure in hypertension. Dual processes of remodeling and growth. , 1993, Hypertension.

[55]  M. Mulvany.  A reduced elastic modulus of vascular wall components in hypertension? , 1992, Hypertension.

[56]  M. Mulvany,et al.  Structure and function of small arteries. , 1990, Physiological reviews.

[57]  M. Sporn,et al.  Transforming growth factor-beta. Major role in regulation of extracellular matrix. , 1990, Annals of the New York Academy of Sciences.

[58]  M. Mulvany,et al.  Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. , 1989, Journal of hypertension.

[59]  M. Sporn,et al.  Transforming Growth Factor‐β , 1990 .

[60]  A. Heagerty,et al.  Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives. , 1987, Circulation research.

[61]  M. Mulvany,et al.  Direct Evidence that the Greater Contractility of Resistance Vessels in Spontaneously Hypertensive Rats is Associated with a Narrowed Lumen, a Thickened Media, and an Increased Number of Smooth Muscle Cell Layers , 1978, Circulation research.